GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 7, 2025
GlobeImmune Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | 2009 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '16 Mar 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2009 - 2010 |
| 6.21 | 6.46 | 5.97 | 22.52 | 14.64 | 5.11 | Upgrade | |
Revenue Growth (YoY) | 8.31% | 8.24% | -73.50% | 53.80% | 186.65% | 25.57% | Upgrade |
Cost of Revenue | 2.08 | 2.65 | 4.99 | 9.02 | 10.03 | 8.38 | Upgrade |
Gross Profit | 4.13 | 3.81 | 0.97 | 13.49 | 4.61 | -3.27 | Upgrade |
Selling, General & Admin | 4.29 | 4.55 | 4.28 | 3.17 | 5.95 | 4.69 | Upgrade |
Research & Development | 1.78 | 1.84 | 2.22 | 1.86 | 1.7 | 3.68 | Upgrade |
Operating Expenses | 6.2 | 6.58 | 6.79 | 5.81 | 8.58 | 9.32 | Upgrade |
Operating Income | -2.07 | -2.77 | -5.82 | 7.69 | -3.97 | -12.59 | Upgrade |
Interest Expense | - | - | -3.89 | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | - | - | -1.86 | 1.9 | 1.95 | -1.13 | Upgrade |
EBT Excluding Unusual Items | -2.07 | -2.77 | -11.57 | 9.59 | -2.01 | -13.72 | Upgrade |
Other Unusual Items | - | - | -4.69 | - | - | - | Upgrade |
Pretax Income | -2.07 | -2.77 | -16.26 | 9.59 | -2.01 | -13.72 | Upgrade |
Income Tax Expense | - | - | - | 0.12 | - | - | Upgrade |
Net Income | -2.07 | -2.77 | -16.26 | 9.48 | -2.01 | -13.72 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | 7.17 | 12.89 | 12.1 | 11.32 | Upgrade |
Net Income to Common | -2.07 | -2.77 | -23.43 | -3.41 | -14.12 | -25.04 | Upgrade |
Shares Outstanding (Basic) | 6 | 6 | 3 | 0 | 0 | 0 | Upgrade |
Shares Outstanding (Diluted) | 6 | 6 | 3 | 0 | 0 | 0 | Upgrade |
Shares Change (YoY) | 32.85% | 97.33% | 3050.27% | 3.52% | 1.74% | 2.52% | Upgrade |
EPS (Basic) | -0.36 | -0.48 | -8.04 | -36.84 | -157.97 | -285.04 | Upgrade |
EPS (Diluted) | -0.36 | -0.48 | -8.04 | -36.84 | -157.97 | -285.04 | Upgrade |
Free Cash Flow | -5.92 | -7.17 | -10.35 | 3.92 | -13.18 | -5.14 | Upgrade |
Free Cash Flow Per Share | -1.03 | -1.25 | -3.55 | 42.36 | -147.43 | -58.48 | Upgrade |
Gross Margin | 66.52% | 58.99% | 16.33% | 59.92% | 31.48% | -64.07% | Upgrade |
Operating Margin | -33.30% | -42.85% | -97.53% | 34.14% | -27.09% | -246.55% | Upgrade |
Profit Margin | -33.30% | -42.85% | -392.78% | -15.14% | -96.43% | -490.25% | Upgrade |
Free Cash Flow Margin | -95.24% | -110.96% | -173.39% | 17.41% | -90.00% | -100.59% | Upgrade |
EBITDA | -1.94 | -2.58 | -5.52 | 8.46 | -3.04 | -11.64 | Upgrade |
EBITDA Margin | -31.25% | -39.95% | -92.58% | 37.56% | -20.77% | -227.91% | Upgrade |
D&A For EBITDA | 0.13 | 0.19 | 0.3 | 0.77 | 0.93 | 0.95 | Upgrade |
EBIT | -2.07 | -2.77 | -5.82 | 7.69 | -3.97 | -12.59 | Upgrade |
EBIT Margin | -33.30% | -42.85% | -97.53% | 34.14% | -27.09% | -246.55% | Upgrade |
Effective Tax Rate | - | - | - | 1.21% | - | - | Upgrade |
Revenue as Reported | 6.21 | 6.46 | 5.97 | 22.52 | 14.64 | 5.11 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.